Selected research
Industry Growth & Trends
Global Sodium Iodine (131I) Drugs Industry Growth and Trends Forecast to 2032
Market perspective
The global Sodium Iodine (131I) Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Sodium Iodine (131I) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Sodium Iodine (131I) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Sodium Iodine (131I) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Sodium Iodine (131I) Drugs include Hta Co., Ltd, Yantai Dongcheng Biochemicals Co.,Ltd., Chengdu Gaotong Isotope Co.,Ltd., Mallinckrodt, Jubilant Radiopharma, International Isotopes, BWXT Medical Ltd, Bracco and AnazaoHealth, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Sodium Iodine (131I) Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Sodium Iodine (131I) Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sodium Iodine (131I) Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sodium Iodine (131I) Drugs.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Sodium Iodine (131I) Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Sodium Iodine (131I) Drugs Market by Company
Hta Co., Ltd
Yantai Dongcheng Biochemicals Co.,Ltd.
Chengdu Gaotong Isotope Co.,Ltd.
Mallinckrodt
Jubilant Radiopharma
International Isotopes
BWXT Medical Ltd
Bracco
AnazaoHealth
Sodium Iodine (131I) Drugs Segment by Type
Sodium Iodine [131I] Capsules
Sodium iodine [131I] Oral Solution
Sodium Iodine (131I) Drugs Segment by Application
Diagnosis and Investigation
Thyroid Cancer
Hyperthyroidism
Sodium Iodine (131I) Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sodium Iodine (131I) Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sodium Iodine (131I) Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sodium Iodine (131I) Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sodium Iodine (131I) Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Sodium Iodine (131I) Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Sodium Iodine [131I] Capsules
- Sodium iodine [131I] Oral Solution
Applications
- Diagnosis and Investigation
- Thyroid Cancer
- Hyperthyroidism
Companies covered
- Hta Co., Ltd
- Yantai Dongcheng Biochemicals Co.,Ltd.
- Chengdu Gaotong Isotope Co.,Ltd.
- Mallinckrodt
- Jubilant Radiopharma
- International Isotopes
- BWXT Medical Ltd
- Bracco
- AnazaoHealth
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Sodium Iodine (131I) Drugs Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Sodium Iodine (131I) Drugs Sales Estimates and Forecasts (2021-2032)
- 1.3 Sodium Iodine (131I) Drugs Market by Type
- 1.3.1 Sodium Iodine [131I] Capsules
- 1.3.2 Sodium iodine [131I] Oral Solution
- 1.4 Global Sodium Iodine (131I) Drugs Market Size by Type
- 1.4.1 Global Sodium Iodine (131I) Drugs Market Size Overview by Type (2021-2032)
- 1.4.2 Global Sodium Iodine (131I) Drugs Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Sodium Iodine (131I) Drugs Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Sodium Iodine (131I) Drugs Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Sodium Iodine (131I) Drugs Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Sodium Iodine (131I) Drugs Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Sodium Iodine (131I) Drugs Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Sodium Iodine (131I) Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Sodium Iodine (131I) Drugs Industry Trends
- 2.2 Sodium Iodine (131I) Drugs Industry Drivers
- 2.3 Sodium Iodine (131I) Drugs Industry Opportunities and Challenges
- 2.4 Sodium Iodine (131I) Drugs Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Sodium Iodine (131I) Drugs Revenue (2021-2026)
- 3.2 Global Top Players by Sodium Iodine (131I) Drugs Sales (2021-2026)
- 3.3 Global Top Players by Sodium Iodine (131I) Drugs Price (2021-2026)
- 3.4 Global Sodium Iodine (131I) Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Sodium Iodine (131I) Drugs Major Company Production Sites & Headquarters
- 3.6 Global Sodium Iodine (131I) Drugs Company, Product Type & Application
- 3.7 Global Sodium Iodine (131I) Drugs Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Sodium Iodine (131I) Drugs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Sodium Iodine (131I) Drugs Players Market Share by Revenue in 2025
- 3.8.3 2025 Sodium Iodine (131I) Drugs Tier 1, Tier 2, and Tier 3
4 Sodium Iodine (131I) Drugs Regional Status and Outlook
- 4.1 Global Sodium Iodine (131I) Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Sodium Iodine (131I) Drugs Historic Market Size by Region
- 4.2.1 Global Sodium Iodine (131I) Drugs Sales in Volume by Region (2021-2026)
- 4.2.2 Global Sodium Iodine (131I) Drugs Sales in Value by Region (2021-2026)
- 4.2.3 Global Sodium Iodine (131I) Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Sodium Iodine (131I) Drugs Forecasted Market Size by Region
- 4.3.1 Global Sodium Iodine (131I) Drugs Sales in Volume by Region (2027-2032)
- 4.3.2 Global Sodium Iodine (131I) Drugs Sales in Value by Region (2027-2032)
- 4.3.3 Global Sodium Iodine (131I) Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Sodium Iodine (131I) Drugs by Application
- 5.1 Sodium Iodine (131I) Drugs Market by Application
- 5.1.1 Diagnosis and Investigation
- 5.1.2 Thyroid Cancer
- 5.1.3 Hyperthyroidism
- 5.2 Global Sodium Iodine (131I) Drugs Market Size by Application
- 5.2.1 Global Sodium Iodine (131I) Drugs Market Size Overview by Application (2021-2032)
- 5.2.2 Global Sodium Iodine (131I) Drugs Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Sodium Iodine (131I) Drugs Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Sodium Iodine (131I) Drugs Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Sodium Iodine (131I) Drugs Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Sodium Iodine (131I) Drugs Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Sodium Iodine (131I) Drugs Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Sodium Iodine (131I) Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Hta Co., Ltd
- 6.1.1 Hta Co., Ltd Company Information
- 6.1.2 Hta Co., Ltd Business Overview
- 6.1.3 Hta Co., Ltd Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Hta Co., Ltd Sodium Iodine (131I) Drugs Product Portfolio
- 6.1.5 Hta Co., Ltd Recent Developments
- 6.2 Yantai Dongcheng Biochemicals Co.,Ltd.
- 6.2.1 Yantai Dongcheng Biochemicals Co.,Ltd. Company Information
- 6.2.2 Yantai Dongcheng Biochemicals Co.,Ltd. Business Overview
- 6.2.3 Yantai Dongcheng Biochemicals Co.,Ltd. Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Yantai Dongcheng Biochemicals Co.,Ltd. Sodium Iodine (131I) Drugs Product Portfolio
- 6.2.5 Yantai Dongcheng Biochemicals Co.,Ltd. Recent Developments
- 6.3 Chengdu Gaotong Isotope Co.,Ltd.
- 6.3.1 Chengdu Gaotong Isotope Co.,Ltd. Company Information
- 6.3.2 Chengdu Gaotong Isotope Co.,Ltd. Business Overview
- 6.3.3 Chengdu Gaotong Isotope Co.,Ltd. Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Chengdu Gaotong Isotope Co.,Ltd. Sodium Iodine (131I) Drugs Product Portfolio
- 6.3.5 Chengdu Gaotong Isotope Co.,Ltd. Recent Developments
- 6.4 Mallinckrodt
- 6.4.1 Mallinckrodt Company Information
- 6.4.2 Mallinckrodt Business Overview
- 6.4.3 Mallinckrodt Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Mallinckrodt Sodium Iodine (131I) Drugs Product Portfolio
- 6.4.5 Mallinckrodt Recent Developments
- 6.5 Jubilant Radiopharma
- 6.5.1 Jubilant Radiopharma Company Information
- 6.5.2 Jubilant Radiopharma Business Overview
- 6.5.3 Jubilant Radiopharma Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Jubilant Radiopharma Sodium Iodine (131I) Drugs Product Portfolio
- 6.5.5 Jubilant Radiopharma Recent Developments
- 6.6 International Isotopes
- 6.6.1 International Isotopes Company Information
- 6.6.2 International Isotopes Business Overview
- 6.6.3 International Isotopes Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 International Isotopes Sodium Iodine (131I) Drugs Product Portfolio
- 6.6.5 International Isotopes Recent Developments
- 6.7 BWXT Medical Ltd
- 6.7.1 BWXT Medical Ltd Company Information
- 6.7.2 BWXT Medical Ltd Business Overview
- 6.7.3 BWXT Medical Ltd Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 BWXT Medical Ltd Sodium Iodine (131I) Drugs Product Portfolio
- 6.7.5 BWXT Medical Ltd Recent Developments
- 6.8 Bracco
- 6.8.1 Bracco Company Information
- 6.8.2 Bracco Business Overview
- 6.8.3 Bracco Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Bracco Sodium Iodine (131I) Drugs Product Portfolio
- 6.8.5 Bracco Recent Developments
- 6.9 AnazaoHealth
- 6.9.1 AnazaoHealth Company Information
- 6.9.2 AnazaoHealth Business Overview
- 6.9.3 AnazaoHealth Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 AnazaoHealth Sodium Iodine (131I) Drugs Product Portfolio
- 6.9.5 AnazaoHealth Recent Developments
7 North America by Country
- 7.1 North America Sodium Iodine (131I) Drugs Sales by Country
- 7.1.1 North America Sodium Iodine (131I) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Sodium Iodine (131I) Drugs Sales by Country (2021-2026)
- 7.1.3 North America Sodium Iodine (131I) Drugs Sales Forecast by Country (2027-2032)
- 7.2 North America Sodium Iodine (131I) Drugs Market Size by Country
- 7.2.1 North America Sodium Iodine (131I) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Sodium Iodine (131I) Drugs Market Size by Country (2021-2026)
- 7.2.3 North America Sodium Iodine (131I) Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Sodium Iodine (131I) Drugs Sales by Country
- 8.1.1 Europe Sodium Iodine (131I) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Sodium Iodine (131I) Drugs Sales by Country (2021-2026)
- 8.1.3 Europe Sodium Iodine (131I) Drugs Sales Forecast by Country (2027-2032)
- 8.2 Europe Sodium Iodine (131I) Drugs Market Size by Country
- 8.2.1 Europe Sodium Iodine (131I) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Sodium Iodine (131I) Drugs Market Size by Country (2021-2026)
- 8.2.3 Europe Sodium Iodine (131I) Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Sodium Iodine (131I) Drugs Sales by Country
- 9.1.1 Asia-Pacific Sodium Iodine (131I) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Sodium Iodine (131I) Drugs Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Sodium Iodine (131I) Drugs Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Sodium Iodine (131I) Drugs Market Size by Country
- 9.2.1 Asia-Pacific Sodium Iodine (131I) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Sodium Iodine (131I) Drugs Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Sodium Iodine (131I) Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Sodium Iodine (131I) Drugs Sales by Country
- 10.1.1 South America Sodium Iodine (131I) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Sodium Iodine (131I) Drugs Sales by Country (2021-2026)
- 10.1.3 South America Sodium Iodine (131I) Drugs Sales Forecast by Country (2027-2032)
- 10.2 South America Sodium Iodine (131I) Drugs Market Size by Country
- 10.2.1 South America Sodium Iodine (131I) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Sodium Iodine (131I) Drugs Market Size by Country (2021-2026)
- 10.2.3 South America Sodium Iodine (131I) Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Sodium Iodine (131I) Drugs Sales by Country
- 11.1.1 Middle East and Africa Sodium Iodine (131I) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Sodium Iodine (131I) Drugs Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Sodium Iodine (131I) Drugs Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Sodium Iodine (131I) Drugs Market Size by Country
- 11.2.1 Middle East and Africa Sodium Iodine (131I) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Sodium Iodine (131I) Drugs Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Sodium Iodine (131I) Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Sodium Iodine (131I) Drugs Value Chain Analysis
- 12.1.1 Sodium Iodine (131I) Drugs Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Sodium Iodine (131I) Drugs Production Mode & Process
- 12.2 Sodium Iodine (131I) Drugs Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Sodium Iodine (131I) Drugs Distributors
- 12.2.3 Sodium Iodine (131I) Drugs Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst